Stifel Financial’s BioTelemetry, Inc. BEAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-15,307
| Closed | -$1.1M | – | 3350 |
|
|
2020
Q4 | $1.1M | Buy |
15,307
+4,299
| +39% | +$225K | ﹤0.01% | 1776 |
|
|
2020
Q3 | $502K | Sell |
11,008
-14,054
| -56% | -$587K | ﹤0.01% | 2091 |
|
|
2020
Q2 | $1.13M | Buy |
25,062
+5,057
| +25% | +$227K | ﹤0.01% | 1474 |
|
|
2020
Q1 | $814K | Sell |
20,005
-199,128
| -91% | -$9.17M | ﹤0.01% | 1564 |
|
|
2019
Q4 | $10.2M | Buy |
219,133
+37,034
| +20% | +$1.6M | 0.02% | 596 |
|
|
2019
Q3 | $7.41M | Sell |
182,099
-60,989
| -25% | -$2.63M | 0.02% | 663 |
|
|
2019
Q2 | $11.7M | Sell |
243,088
-2,397
| -1% | -$126K | 0.03% | 510 |
|
|
2019
Q1 | $15.4M | Sell |
245,485
-67,021
| -21% | -$4.6M | 0.04% | 387 |
|
|
2018
Q4 | $18.7M | Sell |
312,506
-3,888
| -1% | -$233K | 0.06% | 298 |
|
|
2018
Q3 | $20.4M | Sell |
316,394
-135,606
| -30% | -$7.57M | 0.06% | 299 |
|
|
2018
Q2 | $20.3M | Buy |
452,000
+13,162
| +3% | +$525K | 0.06% | 302 |
|
|
2018
Q1 | $13.7M | Buy |
438,838
+37,365
| +9% | +$1.23M | 0.04% | 414 |
|
|
2017
Q4 | $12M | Sell |
401,473
-2,270
| -0.6% | -$65.7K | 0.04% | 453 |
|
|
2017
Q3 | $13.3M | Buy |
403,743
+82,358
| +26% | +$2.85M | 0.05% | 398 |
|
|
2017
Q2 | $10.8M | Buy |
+321,385
| New | +$9.59M | 0.04% | 444 |
|
Other funds holding BEAT
Stifel Financial's BEAT Position: Q1 2021 in Review
Stifel Financial sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 15,307 shares — an estimated $1.1M sold.
Stifel Financial first reported a position in BEAT in Q2 2017 and held it in 15 quarters. The position peaked at $20.4M in Q3 2018. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.
- Stifel Financial reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
- Stifel Financial sold 15,307 BioTelemetry, Inc. shares in Q1 2021, an estimated $1.1M.
- Stifel Financial first reported a position in BioTelemetry, Inc. in Q2 2017 and held it in 15 quarters.
- Stifel Financial's BioTelemetry, Inc. position peaked at $20.4M in Q3 2018.
- 1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.
Based on Stifel Financial's 13F filing for Q1 2021, filed 14 May 2021.